1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A comparative study of the effects of the 1872 storm and coastal flood risk management in denmark, germany, and sweden
(
- Contribution to journal › Article
-
Mark
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer : The Primary Results of the PRONOUNCE Randomized Trial
(
- Contribution to journal › Article
- 2015
-
Mark
Coveted Relic : The Khasarpani Idol Of Bhutan
2015) p.497-512(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2014
-
Mark
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
(
- Contribution to journal › Article
- 2013
-
Mark
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
(
- Contribution to journal › Article
- 2009
-
Mark
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
(
- Contribution to journal › Article
- 2008
-
Mark
Nordic trial of methylprednisolone as add-on therapy to interferon-beta for the treatment of relapsing-remitting multiple sclerosis
2008) 13th Annnual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis In Multiple Sclerosis Journal 14. p.299-300(
- Contribution to journal › Published meeting abstract